These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 21084966

  • 1. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin.
    Nurmohamed SA, Jallah BP, Vervloet MG, Beishuizen A, Groeneveld AB.
    ASAIO J; 2011; 57(1):48-52. PubMed ID: 21084966
    [Abstract] [Full Text] [Related]

  • 2. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
    de Pont AC, Bouman CS, Bakhtiari K, Schaap MC, Nieuwland R, Sturk A, Hutten BA, de Jonge E, Vroom MB, Meijers JC, Büller HR.
    ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
    [Abstract] [Full Text] [Related]

  • 3. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S.
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [Abstract] [Full Text] [Related]

  • 4. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, Vervloet MG, Beishuizen A, Girbes AR, Ter Wee PM, Groeneveld AB, CASH study group.
    Crit Care; 2014 Aug 16; 18(4):472. PubMed ID: 25128022
    [Abstract] [Full Text] [Related]

  • 5. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
    Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB.
    Blood Purif; 2007 Aug 16; 25(4):316-23. PubMed ID: 17700015
    [Abstract] [Full Text] [Related]

  • 6. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study.
    Fabbri LP, Nucera M, Al Malyan M, Becchi C.
    Acta Anaesthesiol Scand; 2010 Jan 16; 54(1):92-7. PubMed ID: 19650808
    [Abstract] [Full Text] [Related]

  • 7. Regional filter heparinization for continuous veno-venous hemofiltration in liver transplant recipients.
    Biancofiore G, Esposito M, Bindi L, Stefanini A, Bisà M, Boldrini A, Consani G, Filipponi F, Mosca F.
    Minerva Anestesiol; 2003 Jun 16; 69(6):527-34; 534-8. PubMed ID: 14564251
    [Abstract] [Full Text] [Related]

  • 8. Real-time circuit pressures correlate poorly with circuit longevity in anticoagulant-free, predilution continuous venovenous hemofiltration.
    Tan CS, Tan HK, Choong HL.
    Blood Purif; 2011 Jun 16; 32(1):15-20. PubMed ID: 21252502
    [Abstract] [Full Text] [Related]

  • 9. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M, Schmid ER, Binswanger U, Schuepbach R, Aerne D, Schmidlin D.
    Wien Klin Wochenschr; 2002 Feb 15; 114(3):108-14. PubMed ID: 12060967
    [Abstract] [Full Text] [Related]

  • 10. Comparison of solute clearance in three modes of continuous renal replacement therapy.
    Parakininkas D, Greenbaum LA.
    Pediatr Crit Care Med; 2004 May 15; 5(3):269-74. PubMed ID: 15115566
    [Abstract] [Full Text] [Related]

  • 11. Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control.
    Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R.
    Nephron Clin Pract; 2003 May 15; 94(4):c94-8. PubMed ID: 12972719
    [Abstract] [Full Text] [Related]

  • 12. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A, Ross EA.
    Am J Kidney Dis; 2005 Nov 15; 46(5):908-18. PubMed ID: 16253732
    [Abstract] [Full Text] [Related]

  • 13. Experimental and Clinical Evaluation of Predilution and Postdilution Continuous Venovenous Hemofiltration on Clearance Characteristics.
    Chihara S, Masuda Y, Yamakage M.
    ASAIO J; 2017 Nov 15; 63(2):229-234. PubMed ID: 27861424
    [Abstract] [Full Text] [Related]

  • 14. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit.
    Kumar VA, Craig M, Depner TA, Yeun JY.
    Am J Kidney Dis; 2000 Aug 15; 36(2):294-300. PubMed ID: 10922307
    [Abstract] [Full Text] [Related]

  • 15. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP, Chan KC, Yan WW.
    Ther Apher Dial; 2012 Feb 15; 16(1):81-6. PubMed ID: 22248200
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of separated system continuous venovenous hemofiltration in critical acute kidney injury.
    Susantitaphong P, Tiranathanagul K, Srisawat N, Katavetin P, Praditpornsilpa K, Eiam-Ong S.
    Ther Apher Dial; 2011 Oct 15; 15(5):475-80. PubMed ID: 21974701
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
    Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M.
    Crit Care Med; 1994 Nov 15; 22(11):1774-81. PubMed ID: 7956281
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.